---
title: "Ransomware in US Health Care: Faster Exploitation and Smaller Breaches, 2016–2026"
id: "medrxiv-6-the-shrinking-grace-period-and-the-downsizing-of-ransomware-victims"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-the-shrinking-grace-period-and-the-downsizing-of-ransomware-victims"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Ransomware in US Health Care: Faster Exploitation and Smaller Breaches, 2016–2026
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-the-shrinking-grace-period-and-the-downsizing-of-ransomware-victims
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators linked the **CISA Known Exploited Vulnerabilities** catalog with CVE publication dates to measure time from disclosure to confirmed exploitation, using 1,748 catalog entries as the basis for the vulnerability timeline analysis. - The team also examined 8,029 breach reports from the **HHS Office for Civil Rights Breach Portal**, restricting analysis to hacking/IT incidents at health care providers to assess breach-size trends. - Median time to confirmed exploitation fell to 24 days for vulnerabilities published in late 2021–mid 2022, dropped to 0 days for CVEs published in the latter half of 2022, and was 6 days for publications in 2023–2025, with no significant shortening within 2023–2025 (P = .40), investigators reported. - Roughly one-quarter of exploited vulnerabilities were used on or before their public disclosure date, indicating that immediate exploitation is common. - In provider hacking breaches, the proportion affecting fewer than 5,000 individuals decreased from 42% in 2016 to 32% in 2022 (trend P = .004), then increased to 46% in 2025 (P < .001), indicating a post-2022 shift toward smaller events. - Authors concluded the disclosure-to-exploitation window narrowed to about a week before broad generative AI availability and that the post-2022 trend moves breaches toward smaller targets, a pattern that undermines defenses relying primarily on rapid patching. - The study used only publicly available, aggregate data sources; processed data and analysis code are available from the corresponding author on request. - All authors are employees of Centralmedience Co., Ltd.; no external funding was reported. - The report is a preprint and has not undergone peer review; the authors noted the preprint status and that findings should not guide clinical practice.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=kjBtxFxxGGwb3EfjL0zRtcMOAKkGnKCxvctdUNvWDMc-1795144150.4314406-1.2.1.1-Zmn4IUnVIFjBBJcLpgAxWCM6dTYihQ5Pk3erm9RzOYpKGsY9LGgrAIi4WR8ShKEo) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # The Shrinking Grace Period and the Downsizing of Ransomware Victims: Exploitation Timelines and Breach Size Among US Health Care Providers, 2016-2026 [ View ORCID Profile](http://orcid.org/0009-0004-0976-6798)Ryutaro Nakagawa, [ View ORCID Profile](http://orcid.org/0009-0002-9184-3566)Yuya Yasuhara, [ View ORCID Profile](http://orcid.org/0009-0001-1065-9621)Akiyo Shimoyama, [ View ORCID Profile](http://orcid.org/0009-0008-7819-3988)Yuki Nishi, [ View ORCID Profile](http://orcid.org/0009-0001-5648-3289)Yuki Kubota doi: https://doi.org/10.64898/2026.11.17.26368300 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Ryutaro Nakagawa Centralmedience Co., Ltd. * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ryutaro%2BNakagawa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nakagawa%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARyutaro%2BNakagawa%2B) * [ORCID record for Ryutaro Nakagawa](http://orcid.org/0009-0004-0976-6798 "Open in new tab") * For correspondence: ryutarou.na@gmail.com Yuya Yasuhara Centralmedience Co., Ltd. * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuya%2BYasuhara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yasuhara%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuya%2BYasuhara%2B) * [ORCID record for Yuya Yasuhara](http://orcid.org/0009-0002-9184-3566 "Open in new tab") Akiyo Shimoyama Centralmedience Co., Ltd. * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Akiyo%2BShimoyama%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shimoyama%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAkiyo%2BShimoyama%2B) * [ORCID record for Akiyo Shimoyama](http://orcid.org/0009-0001-1065-9621 "Open in new tab") Yuki Nishi Centralmedience Co., Ltd. * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuki%2BNishi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nishi%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuki%2BNishi%2B) * [ORCID record for Yuki Nishi](http://orcid.org/0009-0008-7819-3988 "Open in new tab") Yuki Kubota Centralmedience Co., Ltd. * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuki%2BKubota%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kubota%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuki%2BKubota%2B) * [ORCID record for Yuki Kubota](http://orcid.org/0009-0001-5648-3289 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349193/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349193/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349193/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349193/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349193/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objectives: To examine how quickly software vulnerabilities are exploited after public disclosure, and whether hacking breaches at US health care providers changed in size after 2021, a period in which earlier studies had found attacks concentrating on large organizations. Methods: Retrospective analysis of public data. We linked the CISA Known Exploited Vulnerabilities catalog (1,748 entries) with CVE publication dates to measure time to confirmed exploitation by half-year of publication (2021-2025). We also analyzed 8,029 breach reports submitted to the HHS Office for Civil Rights, focusing on hacking/IT incidents at health care providers. Results: Median time to confirmed exploitation was 24 days for vulnerabilities published from late 2021 to mid 2022, 0 days for those published in the second half of 2022, and 6 days in 2023-2025, with no further shortening across 2023-2025 (P = .40). About a quarter were exploited on or before the day of disclosure. Among provider hacking breaches, the share affecting fewer than 5,000 people fell from 42% in 2016 to 32% in 2022 (trend P = .004) and rose to 46% in 2025 (P Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1 "A new liability-based rare-variant burden test identifies a novel genetic association between HTRA3 and idiopathic pulmonary fibrosis")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.19.26368142v1 "Emergency Manual Peritoneal Dialysis Using Adapted Nasogastric Tubes Versus Tenckhoff Catheters for Severe Acute Kidney Injury in Neonates and Infants: A Retrospective Cohort Study") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.17.26368300.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.17.26368300.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) The Shrinking Grace Period and the Downsizing of Ransomware Victims: Exploitation Timelines and Breach Size Among US Health Care Providers, 2016-2026 Ryutaro Nakagawa, Yuya Yasuhara, Akiyo Shimoyama, Yuki Nishi, Yuki Kubota medRxiv 2026.11.17.26368300; doi: https://doi.org/10.64898/2026.11.17.26368300 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368300v1%26text%3DThe%2520Shrinking%2520Grace%2520Period%2520and%2520the%2520Downsizing%2520of%2520Ransomware%2520Victims%253A%2520Exploitation%2520Timelines%2520and%2520Breach%2520Size%2520Among%2520US%2520Health%2520Care%2520Providers%252C%25202016-2026 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368300v1%26t%3DThe%2520Shrinking%2520Grace%2520Period%2520and%2520the%2520Downsizing%2520of%2520Ransomware%2520Victims%253A%2520Exploitation%2520Timelines%2520and%2520Breach%2520Size%2520Among%2520US%2520Health%2520Care%2520Providers%252C%25202016-2026 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368300v1%26title%3DThe%2520Shrinking%2520Grace%2520Period%2520and%2520the%2520Downsizing%2520of%2520Ransomware%2520Victims%253A%2520Exploitation%2520Timelines%2520and%2520Breach%2520Size%2520Among%2520US%2520Health%2520Care%2520Providers%252C%25202016-2026%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368300v1%26title%3DThe%2520Shrinking%2520Grace%2520Period%2520and%2520the%2520Downsizing%2520of%2520Ransomware%2520Victims%253A%2520Exploitation%2520Timelines%2520and%2520Breach%2520Size%2520Among%2520US%2520Health%2520Care%2520Providers%252C%25202016-2026 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368300) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (926) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5051) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16336) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1248) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7320) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (758) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1100) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5337) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1846) * [Hematology](https://www.medrxiv.org/collection/hematology) (602) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1388) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16533) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1208) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (755) * [Neurology](https://www.medrxiv.org/collection/neurology) (7654) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1140) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1303) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3763) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1104) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (472) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (725) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1875) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (790) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6180) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10040) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2554) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1535) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1280) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (664) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (812) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (809) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to pre
## Related Clinical Research

- [Maternal Vitamin D Status and Preeclampsia Risk in Kenyan Pregnant Women: A Matched Case–Control S](https://medichelpline.com/clinical-feed/plos-one-12-maternal-serum-vitamin-d-levels-and-preeclampsia-among-kenyan-pregnant-women-a.md)
- [Machine learning model predicts ICU delirium in adults with acute kidney injury](https://medichelpline.com/clinical-feed/pubmed-43063111.md) (DOI: 10.1097/MD.0000000000051672)
- [Emergency Peritoneal Dialysis in Neonates: Nasogastric Tube Access vs Tenckhoff Catheters](https://medichelpline.com/clinical-feed/medrxiv-3-emergency-manual-peritoneal-dialysis-using-adapted-nasogastric-tubes-versus.md)
- [Single-nucleus long-read RNA sequencing finds isoform shifts in mouse acute kidney injury](https://medichelpline.com/clinical-feed/biorxiv-21-single-nucleus-long-read-rna-sequencing-reveals-isoform-usage-shifts-in-mouse.md)
- [Bariatric Surgery Perioperative Risk Varies by Chronic Kidney Disease Stage, NIS 2016–2022](https://medichelpline.com/clinical-feed/pubmed-42983176.md) (DOI: 10.1007/s11695-026-09003-7)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.